Global Cattle Healthcare Market 2024-2028

Description

List of Tables

The cattle healthcare market is forecasted to grow by USD 4.47 bn during 2023-2028, accelerating at a CAGR of 8.91% during the forecast period. The report on the cattle healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising burden of cattle diseases, growing awareness among cattle farmers on importance of preventive healthcare measures, and increasing demand for beef and dairy products worldwide.

Technavio's cattle healthcare market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.53%
CAGR	8.91%
Incremental Value	$4.47bn

By Type

Beef cattle
Dairy cattle

By Product

Pharmaceuticals
Feed additives
Vaccines
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising shift towards animal farming as one of the prime reasons driving the cattle healthcare market growth during the next few years. Also, advancements in veterinary medicine and technology and growing trend of telemedicine in veterinary care facilitates will lead to sizable demand in the market.

The report on the cattle healthcare market covers the following areas:

Cattle healthcare market sizing
Cattle healthcare market forecast
Cattle healthcare market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cattle healthcare market vendors that include Biozyme Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., IDEXX Laboratories Inc., ImmuCell Corp., Indian Immunologicals Ltd., Innovative Diagnostics, International Health Care Ltd., Kyoritsuseiyaku Corp., Merck and Co. Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corp., Thermo Fisher Scientific Inc., Vamso Biotec Pvt. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Zovix Pharmaceuticals. Also, the cattle healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77493

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global cattle healthcare market 2018 - 2022
4.2 Type Segment Analysis 2018 - 2022
4.3 Products Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Type

6.1 Market segments
6.2 Comparison by Type
6.3 Beef cattle - Market size and forecast 2023-2028
6.4 Dairy cattle - Market size and forecast 2023-2028
6.5 Market opportunity by Type

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 Pharmaceuticals - Market size and forecast 2023-2028
7.4 Feed additives - Market size and forecast 2023-2028
7.5 Vaccines - Market size and forecast 2023-2028
7.6 Others - Market size and forecast 2023-2028
7.7 Market opportunity by Product

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 France - Market size and forecast 2023-2028
9.9 India - Market size and forecast 2023-2028
9.10 Germany - Market size and forecast 2023-2028
9.11 China - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Biozyme Inc.
12.4 Boehringer Ingelheim International GmbH
12.5 Ceva Sante Animale
12.6 Elanco Animal Health Inc.
12.7 IDEXX Laboratories Inc.
12.8 ImmuCell Corp.
12.9 Innovative Diagnostics
12.10 Kyoritsuseiyaku Corp.
12.11 Merck and Co. Inc.
12.12 Norbrook Laboratories Ltd.
12.13 Phibro Animal Health Corp.
12.14 Thermo Fisher Scientific Inc.
12.15 Vetoquinol SA
12.16 Virbac Group
12.17 Zoetis Inc.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations